A prospective randomized study evaluating the necessity of narcotics following ureteroscopy for urinary stone disease

• Published in: World journal of urology Vol. 40; no. 10; pp. 2567 - 2573
• Main Authors: Bamberger, Jacob N., Gallante, Blair, Khusid, Johnathan A., Yaghoubian, Alan, Sadiq, Areeba, Shimonov, Roman, Zampini, Anna M., Chandhoke, Ryan A., Atallah, William, Gupta, Mantu
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2022; Springer Nature B.V
• Subjects: Acetaminophen; Analgesics; Counseling; Ibuprofen; Implants; Lithotripsy; Medicine; Medicine & Public Health; Narcotics; Nephrology; Nonsteroidal anti-inflammatory drugs; Oncology; Opioids; Original Article; Oxycodone; Pain; Patients; Tablets; Urology; Opioid; Nephrolithiasis; Pain counseling; Ureteroscopy; Lithotripsy
• ISSN: 1433-8726; 0724-4983; 1433-8726
• DOI: 10.1007/s00345-022-04099-9

Purpose To evaluate the efficacy of non-narcotic analgesics and preoperative counseling in managing postoperative pain and narcotic use following ureteroscopic laser lithotripsy (URS). Methods Adult patients at a single academic center undergoing URS for nephrourolithiasis were recruited. After informed consent, subjects were randomized into three groups: NARC—15 tablets oxycodone-acetaminophen 5/325 mg (A-OXY), 2. NSAID—15 tablets ibuprofen (IBU) 600 mg, 3. CNSL—15 tablets A-OXY, 15 tablets IBU, and preoperative counseling from the surgeon to avoid narcotic if possible. Patients who did not receive an intraoperative stent were excluded. At the time of stent removal subjects completed the Universal Stent Symptom Questionnaire (USSQ), and a pill count was performed. USSQ pain indices were the primary study endpoint. Results Of 115 patients enrolled, 104 met the primary endpoint and were included in the analysis. No significant differences were noted in patient demographic, clinical, or operative characteristics. No differences were noted in median USSQ pain indices. The CNSL group used a significantly lower median number of A-OXY pills compared to the NARC group (2.4 vs. 5.4, p  = 0.001) and less IBU compared to the NSAID group (3.1 vs. 5.9, p  = 0.008). No differences in median total pill count, office calls, medication requests, nor ED visits were noted. Conclusion Our data suggest that patients can achieve equivalent postoperative analgesic satisfaction with non-narcotics compared to opiates following URS. Further, counseling patients on postoperative pain before surgery can reduce the total number of postoperative narcotic and non-narcotic medications taken. We suggest surgeons strongly consider omission of narcotic prescriptions following non-complicated URS.